Search Results 291-300 of 17057 for Famotidine

1. Tbo-filgrastim (subcutaneous route) - Side effects & dosage - Mayo Clinic

   Tbo-filgrastim injection is used to treat severe neutropenia (low white blood cells) that is caused by cancer medicines. It is a synthetic (man-made) form of a ...

2. Olmesartan and hydrochlorothiazide (oral route) - Mayo Clinic

   This can damage the blood vessels of the brain, heart, and kidneys, resulting in a stroke, heart failure, or kidney failure. Lowering blood pressure can reduce ...

3. Fitusiran (subcutaneous route) - Side effects & dosage - Mayo Clinic

   Fitusiran injection is used to prevent or decrease the frequency of bleeding episodes in patients with hemophilia A or B with or without factor VIII or IX ...

4. Return of Results of Pharmacogenomic Testing for Genes Involved in Metabolism of 5FU and Capecitibine - Mayo Clinic

   About this study. A group of Mayo Clinic Biobank participants were genotyped for genetic variants as part of a separate study and a subset were found to be ...

5. Ceftazidime and avibactam (intravenous route) - Side effects & uses - Mayo Clinic

   Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you ...

6. Massage Therapy at Mayo Clinic

   An error occurred, please try again later. Copy for customer care: session ID undefined. Try again. Share · Tweet . VID-20170394.

7. Deferiprone (oral route) - Side effects & dosage - Mayo Clinic

   Deferiprone is used to remove excess iron from the body in patients with thalassemia, sickle cell disease, or anemia who have blood transfusions. Deferiprone is ...

8. A Study Assess the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride HCl) Oral Solution in Children and Young Adults With Dravet Syndrome - Mayo Clinic

   A Study Assess the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride HCl) Oral Solution in Children and Young Adults With Dravet Syndrome · Overview.

9. The Effect of Glutamine on Intestinal Permeability and Symptoms in Patients with Functional Dyspepsia in a Randomized, Placebo-Controlled Trial - Mayo Clinic

   Of note, patients taking PPIs will be given the opportunity to discontinue their PPI in favor of famotidine 20 mg daily for 2 weeks before enrollment.

10. A Study Of The Drugs Selumetinib Vs. Carboplatin And Vincristine In Patients With Low-Grade Glioma - Mayo Clinic

    About this study. This study aims to demonstrate that the efficacy of treatment with selumetinib as measured by event-free survival (EFS) is non-inferior ...